Industry

– Facial Paralysis Prevention study initiated and first patient enrolled evaluating the safety and efficacy of NTX-001 following facial nerve surgery – Ongoing Trauma Phase 2 study hits enrollment milestone with topline data expected in 2nd half of 2023 PHILADELPHIA–(BUSINESS WIRE)–Neuraptive Therapeutics, Inc. (Neuraptive), a clinical-stage biotechnology company dedicated to developing novel therapeutics and medical … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Tinnitus – Pipeline Insight, 2022” drug pipelines has been added to ResearchAndMarkets.com’s offering. The publisher’s, “Tinnitus – Pipeline Insight, 2022,” report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in Tinnitus pipeline landscape. A detailed picture of the Tinnitus pipeline landscape is provided which includes the disease overview and Tinnitus treatment … [Read more…]

MONTREAL–(BUSINESS WIRE)–#DermatologyCRO–Innovaderm’s involvement in all phases of the clinical development of tapinarof culminated with a tremendous achievement: the recent approval of Dermavant Sciences’ VTAMA® (tapinarof) cream by the FDA for the treatment of plaque psoriasis in adults. Discovered in Canada, tapinarof is approved in the United States for the management of psoriasis, a chronic skin … [Read more…]

New addition to Rheonix leadership adds expertise in infectious diseases and global epidemic response ITHACA, N.Y.–(BUSINESS WIRE)–Rheonix Inc., an innovative leader in highly multiplexed pathogen detection, announced the appointment of Stephen J. Thomas, M.D., as Chief Medical Officer and member of the Rheonix Board of Directors. “I am delighted to welcome Dr. Thomas to the … [Read more…]

PERTH, Australia & HEIDELBERG, Germany–(BUSINESS WIRE)–#biotechnology–Ozgene and Gen-H are pleased to announce our working partnership supporting Ozgene’s new OzBIG capability. Ozgene Pty Ltd is a privately held CRO based in Perth, Australia providing custom genetically engineered mice for academic and commercial researchers worldwide. Gen-H GmbH is a privately held CRO based in Heidelberg, Germany providing … [Read more…]

Voluson Expert 22 represents a major step forward in ultrasound innovation from a market leader in Women’s Health Ultrasound Next-generation architecture behind Voluson Expert 22 includes Voluson graphic-based beam former technology; AI powered tools; and customizable touch panel, color and lighting options CHICAGO–(BUSINESS WIRE)–GE Healthcare today unveiled its most advanced ultrasound yet, the next-generation Voluson™ … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Biotech Flavors Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2028” report has been added to ResearchAndMarkets.com’s offering. The report predicts the global biotech flavors market to grow with a significant CAGR over the forecast period from 2022-2028. The report on the global biotech flavors market provides qualitative and quantitative … [Read more…]

MONTREAL–(BUSINESS WIRE)–#cancer—Imagia Canexia Health, a genomics-based cancer treatment testing company that accelerates access to precision care by combining AI expertise with advanced molecular biopsy solutions, and Anwa Medical Co (“Anwa”), a leading genomic diagnostics laboratory group in the Kingdom of Saudi Arabia (“Saudi Arabia”), today announced that they have entered a Memorandum of Understanding (MOU) … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Bio Decontamination Market by Product (Equipment, Services, Consumables), Agent (Hydrogen Peroxide, Nitrogen, Peracetic Acid), Type (Room Decontamination, Chamber Decontamination), End User (Hospitals & Healthcare Facilities) – Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering. The global bio decontamination market is projected to reach USD 227 million by 2027 from USD … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Royalty Rates for Medical Devices 2022” report has been added to ResearchAndMarkets.com’s offering. Royalty Rates for Medical Devices & Diagnostics is all about royalty rates from the medical device industry. It is based on decades of research. The rates in this book can be used for negotiating licenses, valuing medical technology and establishing … [Read more…]